appendix 3b new shares, page-60

"IMO it was heavily shorted on the nasdaq and Friday night US, was no more than short covering"
TL I don't disagree with that, but if the price was taken down with shorts(fake stock)then when they have to cover it is just the price returning to where it should be. My opinion is the market maker is doing most of it to create liquidity and profits.
So far PBT2 is headed for a phase3 in HD based on Reach2HD results. That trial identified s stat sig improvement in a key cognition measure and a further stat sig improvement over a wider range of cognition measures in a pre specified early stage patient group. Prana liked the results, and more importantly the Huntington's specialists running the trial liked the results.
Based on that alone I think this could move a lot higher.
Now we just need AD results with some plaque reduction.